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INTRODUCTION
It has been approximately 50 years since HC was first reported
and comprise over 60% of all cholangiocarcinomas (1-3). Hepato-
biliary malignant tumors can easily invade to hepatic hilum and
cause obstructive jaundice, and their prognosis remains poor. Cur-
rently, the only curative treatment for HC is radical surgical resec-
tion (4), though in some advanced cases, an extended hepatic
lobectomy or combined resection of major vessels is needed.
Although a large number of HC patients are jaundiced, there is no
established consensus of the operative indication for the patients
with icteric liver. The tumor resection for the icteric HC patients
may be associated with increased postoperative complication (5).
To overcome these problems, several drug protocols have been
introduced. Recent systematic reviews demonstrated that pe-
rioperative administration of glucocorticoids to patients undergo-
ing liver surgery was associated with a significant reduction in
overall morbidity (6). We have already reported that nafamostat
mesilate stabilize the coagulant and fibrinolytic systems and sig-
nificantly reduced the rate of blood transfusion during hepatic
resection (7). Also, “inchinkoto (ICKT)” is one of the most com-
monly used Japanese “Kampo” medicine as a hepatoprotective
agent for resected liver (8).
On the other hand, preoperative biliary drainage (PBD) can be a
feasible option to decrease postoperative complication for such
cases (9). Some authors have reported that the cut-off value of
serum total bilirubin to perform PBD for icteric HC was 2 to 3 mg/dl
(10). However, a consensus on an appropriate cut-off level of total
bilirubin and duration of drainage has not been established yet.
Furthermore, preoperative assessment of functional liver reserve
(FLR) is important in the management of HC patients. ICG has
been used to evaluate FLR before hepatectomy and provides useful
information for clinical decision making regarding the indications
or extent of hepatic resection in patients with injured livers (11, 12).
Although Indocyanine green dye retention rate at 15 minutes
(ICGR15) has been useful, FLR may be underestimated by ICGR
15 in some patients with obstructive jaundice. Therefore, other
reliable functional parameters were needed. Recently, novel tests
of FLR, such as serum HA level (13-15), GSA scintigraphy (16), and
interleukin levels (17), have been used to evaluate post-surgical
complications. Furthermore, the correlation of LHL15 and HH15 to
ICGR15 using a linear regression model and the analysis of indi-
vidual liver segments by dynamic SPECT are easy and convenient
methods for predicting hepatic functional reserve by GSA scintigra-
phy (18-21).
Therefore, our perioperative protocol for HC patients includes :
the drugs (e.g. glucocorticoids, nafamostat mesilate and ICKT),
PBD and preoperative assessment of FLR. In this paper, we study
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about the feasibility of our peri -operative protocol for HC patients
including the drugs, PBD and preoperative assessment of function in
FLR using GSA scintigraphy.
PATIENTS AND METHODS
Study population and preoperative management
Between 2004 and 2010, 20 patients (12 males and 8 females)
were treated for HC at our institute. Jaundice was defined as a
serum T-Bil level2 mg/dl. Among them, 11 patients were jaun-
diced at the first visit, and received biliary drainage (BD) by either
percutaneous transhepatic biliary drainage (PTBD) or endoscopic
naso-biliary drainage (ENBD). After BD, 6 patients were still jaun-
diced before surgery, and patients were divided into two groups as
follows, the icteric group (n=6) and the normal group (n=14).
Adequate PBD was evident by a relief of cholangitis, and an im-
provement in the liver function and/or the nutritional status of the
patient. In our series, blood sampling for serum biochemistry was
completed 2-3 days before surgery. Enhanced computed tomogra-
phy (CT) and ICGR15 was used routinely before surgery. Preop-
erative liver functional reserve was estimated by asiaroscintigra-
phy, which evaluated by Tc-99m galactosyl human serum albumin
(GSA) scintigraphy, ICGR15 and serum hyaluronic acid (HA). Of
these 10 patients, GSA scintigraphy for the additional liver func-
tional reserve evaluation was introduced for evaluating the FLR of
icteric liver.
Preoperative evaluation in liver functional reserve using asia-
roscintigraphy
Preoperatively, the patients underwent asiaroscintigraphy as de-
scribed previously (22). Briefly, the patients received 3 mg of Tc-
GSA (185 MBq ; Nihon Medi-Physics, Nishinomiya, Japan) as a
bolus injection into an antecubital vein. Dynamic images were re-
corded under a large field-of -view gamma camera with a low
energy, all -purpose, parallel -hole collimator centered on the liver
and the precordium. Sequential digital images were acquired to an
online nuclear data processor at 30 s/frame for the first 20 min after
the injection. The hepatic uptake ratio of GSA (LHL15, receptor
index) was calculated by dividing the liver radioactivity at 15 min-
utes by the heart plus liver activity at 15 minutes. Hepatic Single
Photon Emission CT (SPECT) images were acquired after the dy-
namic study. Dynamic SPECT acquisition was performed with a
circular orbit by means of dual detectors equipped with a low en-
ergy, highly resolution collimator. The acquisition time was 30
minutes (30 rotations). After calculation of the functional liver
volume, a planned liver resected line was entered into each sec-
tion of the trans-axial SPECT image (Fig. 2A) and the FRL vol-
ume was calculated (Fig. 2B). The functional FRL was predicted
by 99mTc-GSA was calculated by the following formula ; Remnant
liver LHL15 = LHL15 x remnant liver count / whole liver count.
Perioperative drug protocol
In all patients, orally administration of Japanese kampo medicine
ICKT was introduced. Particular in patients with BD, orally bile
replacement routinely performed. After biliary drainage, ICKT was
orally administered (7.5 g/day) during perioperative period. Fur-
thermore, preoperative steroid (500 mg/body) just before surgery
and intra- and 3 days post-operative nafamostat mesilate (200 mg/
day) was administration intravenously.
Surgical procedures
All the patients underwent hepatic lobectomy with extra-hepatic
bile duct resection and regional lymph nodes dissection for cura-
tive resection. At our institute, curative resection was defined as
histologically negative surgical margins at the hepatic stump of the
bile duct, the duodenal stump of the bile duct, and the excision
surface.
Statistics
All data were expressed as the meanSD. Statistical analyses
were performed using the JMP statistical program (SAS Institute,
Cary, NC, USA). Comparisons of the values between two groups
were performed with Mann-Whitney U test. The correlation coeffi-
cients were analyzed by standard Pearson correlation analysis. Sta-
tistical significance was defined as p0.05.
RESULTS
Patient Characteristics
During the study period, 20 patients underwent major hepatic
resection for HC at our institution. The baseline characteristics of
the each group were outlined in Table 1. The icteric group was
comparable with the normal group with regards to age, sex,
surgical procedure and preoperative serum AST level. In the icteric
group, preoperative serum T-Bil, D-Bil levels were significantly
higher, whereas preoperative serum albumin level was also signifi-
cantly lower, compared to the normal group.
Evaluation of preoperative whole liver functional reserve
Preoperative assessment of whole liver functional reserve was
shown in Fig. 1. ICGR15 was significantly more increased in the
icteric group compared to that in the normal group (icteric vs.
normal : 33.823.6% vs. 10.33.2, p0.05). Also, LHL 15 value of
the icteric group was significantly higher than that of the normal
group (icteric vs. normal : 0.8830.029 vs. 0.9300.023, p0.01).
No significant difference was observed in serum hyaluronic acid
levels between the two groups (icteric vs. normal : 99.053.5 vs.
153.953.8). In other words, whole FLR was decreased in the
icteric group, due to obstructive jaundice.
Evaluation of future remnant functional liver reserve
Preoperatively, 10 patients (the icteric group : n=5, the normal
group : n=5) were evaluated with LHL 15 of future FLR by asia-
roscintigraphy. Actual future remnant FLR after hepatic resection
was calculated by dividing the radioactivity of the region of interest
Table 1. Comparison of baseline characteristics between icteric and
normal group
Factors
Normal liver Icteric liver
p -values
(n=14) (n=6)
Age 746 726 N.S.
Gender (Male/Female) 9/5 3/3 N.S.
Obstructive jaundice (+/-) 5/9 6/0 
Duration of icterus (days) 5 -46 15-62 
Surgical Procedure
(rt. Lobectomy / lt. lobectomy) 6(HPD : 1) / 8 2 / 4 N.S.
AST (IL/L) 7770 6023 N.S.
T-Bil (mg/dl) 1.00.4 5.13.0 0.01
D-Bil (mg/dl) 0.150.07 2.62.0 0.01
ALB (mg/dl) 3.50.4 2.90.2 0.01
HPD : hepatic resection combined with pancreatoduodenectomy
38 K. Yada, et al. Hepatic resection for icteric liver
(ROI) by that of the entire liver plus heart ROIs at fifteen min after
the injection (Fig. 2A). As a result with calculated formula, no sig-
nificant difference were observed in LHL 15 of future remnant FLR
between the two groups (icteric vs. normal : 0.5430.190 vs.
0.5030.159) (Fig. 2B).
Changes of liver injury and postoperative complication after
major hepatectomy
Total bilirubin level was significantly higher in the icteric group,
and remained high up to 3 weeks after surgery. On the other hand,
serum AST levels showed no significant difference between two
groups, and recovered normal range within 1 week in the both
groups (Fig. 3).
Regarding postoperative complication, the number of patients
with postoperative morbidity in the both groups were comparable
(42.9% vs. 33.3%)(Table 2).
DISCUSSION
Hepato-biliary malignant tumors easily invade to hepatic hilum,
and cause invasion to main vessels and occurred obstructive jaun-
dice. Currently, the only curative treatment for HC is radical surgical
resection (4), but in advanced cases, an extended hepatic lobectomy
or combined resection of major vessels. On the other hand, re-
garding to obstructive jaundice, biliary drainage has been per-
formed to prevent liver failure and acute cholangitis. However we
Figure 3
Post -operative course of icteric liver
(A) Post -operative changes in serum AST level
(B) Post -operative changes in serum t-bil level
Serum AST level showed no significant difference between two groups,
and recovered normal range within 1 week in the both groups. Total
bilirubin level was significantly higher in icteric liver group, and re-
mained high up to 3 weeks after surgery (p0.05).
Figure 1
Comparison of liver functional reserve in each group.
(A) Evaluation of LHL15
(B) serum hyaluronic acid level
(C) ICGR15
(D) correction ICGR15
LHL15 was significantly higher in normal group than in icteric group (p
0.05), whereas ICGR15 and correction ICGR15 were significantly higher in
icteric group (p0.05). There was no significant difference between the
two groups in serum HA.
Figure 2
Evaluation of liver functional reserve by SPECT.
(A) A cut line was entered into each section of the transaxial SPECT
image.
Right LHL15 was calculated by dividing the radioactivity of the region of
interest (ROI) by that of the entire liver plus heart ROIs at fifteen min
after the injection.
(B) Remnant liver LHL15 were calculated.
Remnant liver LHL15 was calculated from GSA up take, and there was no
significant defference between two groups.
Table 2. Comparison of postoperative complication between icteric
and normal group
Factors
Normal liver Icteric liver
p -values
(n=14) (n=6)
Post -operative complication (+/-) 6/8 2/4 N.S.
Bile leakage 2 0 
Leakage (hepatico - jejunostomy) 2 1 
Acute pancreatitis 1 0 
Arterial bleeding 1 0 
Cerebral infarction 0 1 
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sometimes experience prolonged hyperbilirubinemia despite ap-
propriate biliary drainage. For those reasons, the treatment strat-
egy for HC patient with obstructive jaundice before surgery is not
well established, and therefore major hepatic resection for icteric
HC patient is still challenging. In this study, we demonstrated that
appropriate BD, the evaluation of FRL, and the effective periopera-
tive drug protocol that successfully enable the surgery for HC with
favorable outcomes. Our important findings are as follows : 1) BD
improved serum T-Bil level below 2 mg/dl in 5 of 11 patients with
jaundice. 2) Although 6 patients were still jaundiced after BD, our
perioperative protocol for icteric HC patients (e.g. preoperative
drug protocol including steroids, nafamostat mesilate, ICKT and
bile replacement) lead to similar short term outcome compared to
non- icteric HC patients. 3) Finally, the accurate evaluation of
future remnant FRL using asiaroscintigraphy was most important
for achieving the successful hepatectomy without postoperative
liver failure.
The usefulness of BD for HC patients remains controversial.
Multiple retrospective studies have shown that BD in jaundiced HC
patients decreases postoperative complications although no im-
provement in mortality or survival has been reported (9, 23-25). On
the other hand, a systematic review comparing BD with no BD in
resectable patients, the authors failed to note a benefit from BD
(26). Although, randomized studies are needed to better address
the potential benefits of PBD in HC, previous studies (9, 23-25, 27)
and our results suggests the benefit of BD for icteric HC patients.
Estimation of FRL is important, because HC patients sometimes
needs extended liver surgery which may lead to postoperative
hyperbilirubinemia, uncontrolled ascites, and intraabdominal in-
fection (28). One study showed that perioperative outcomes of HC
patients with future liver remnant volume of less than 30% was
improved by BD (29). ICG has been used to evaluate FLR before
hepatectomy and provides useful information for clinical decision
making regarding the indications or extent of hepatic resection in
patients with injured livers (11, 12). Although ICGR15 have been
useful, in some patients with obstructive jaundice, functional liver
reserve may be underestimated by ICGR15. Indeed, in our study,
there was considerable dissociation in ICGR15 between the icteric
and normal group. Therefore, other reliable functional parameters
were needed. Recently, novel tests of FLR, such asserum HA level
(13-15), GSA scintigraphy (16), and interleukin levels (17), have
been used to evaluate post hepatectomy complications. Further-
more, correlation of LHL15 and HH15 to ICGR15 using a linear
regression model and the analysis of individual liver segments by
dynamic SPECT are easy and convenient methods for predicting
FLR by GSA scintigraphy (18-21). In our study, there was no sig-
nificant difference between the two groups in serum HA (Fig 1B)
and remnant liver LHL15 calculated fromGSA up take (Fig 2). And
correction ICGR seemed to evaluate precisely icteric FLR (Fig 1D).
Although several recent studies have attempted these analyses to
predict complications (30-34), no distinct criteria or final consen-
sus using these parameters have been widely accepted (35). How-
ever, GSA scintigraphy could accurately evaluate the segmental
FLR, and which could be the best indicator for the decision-
making of major hepatic resection.
Recent systematic review demonstrated that perioperative ad-
ministration of glucocorticoids to patients undergoing liver sur-
gery was associated with a significant reduction in overall morbid-
ity, without increasing the likelihood of infectious complications
and wound healing defects. In addition, steroids significantly re-
duced postoperative blood levels of bilirubin, and of inflammatory
markers such as IL-6, and C-reactive protein whereas there is no
difference in postoperative serum AST and ALT level (6, 36-41). In
our study, administration of glucocorticoids may have reduced
morbidity and postoperative serum bilirubin level in icteric group.
We have already reported that nafamostat mesilate stabilize the
coagulant and fibrinolytic systems and significantly reduced the
rate of blood transfusion in hepatic resection (7). ICKT is one of the
most commonly used Japanese herbal medicines as a hepatopro-
tective agent. Whereas recent experiments studies have clarified
the hepatoprotective effects (choleretic, anti -apoptotic, anti - infla-
mmatory, antifibrotic and antioxidative effect) of ICKT (7, 42-48),
only a few clinical studies exist that examine the benefit of ICKT in
humans (8, 49). Among them, Watanabe et al. revealed the chol-
eretic effect of ICKT on livers of patients with biliary obstruction
due to bile duct carcinoma in Randomized Controlled trial. In our
study, ICKT may be attenuated serum bilirubin level in icteric
group. In our perioperative drug protocol, we have used steroids,
nafamostat mesilate and ICKT. As a result, the number of patients
with postoperative morbidity in the two groups was comparable.
In our summary, although major hepatectomy for the HC pa-
tients with icteric liver can be challenging, appropriate BD, accu-
rate evaluation of FLR according to the each liver segment with or
without biliary congestion, and effective perioperative drug proto-
col enable it successfully with favorable outcomes. Even in HC pa-
tients with icteric liver, accurate assessment of future remnant FLR
and effective perioperative treatment may attribute to successful
hepatectomy and favorable outcomes.
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